|
TS govt takes steps to boost pharma R&D and help industry adopt continuous synthesis for API manufacturing
|
|
A Raju, Hyderabad
November 29 , 2021
|
|
|
The state government of Telangana has taken initiatives to boost research and development (R&D) in the pharmaceutical sector and help the local industry to adopt continuous synthesis for the manufacturing of active pharmaceutical ingredients (APIs).
As part of the initiative, the state government has recently announced the setting up of a multi-industry supported innovation and technology hub for flow chemistry in Hyderabad. This initiative of the government is mainly aimed towards ensuring greater incorporation of flow chemistry techniques during pharma R&D and greater adoption of continuous synthesis for manufacturing of APIs.
In continuation to this initiative, recently the department of Industries government of Telangana led by industries minister K.T Rama Rao, and principal secretary Jayesh Ranjan signed a consortium agreement for setting up the ‘Centre of Excellence’.
The centre of excellence on flow chemistry is set up at Dr Reddy’s Institute of Life Sciences (DRILS). It will receive funding and patronage from Hyderabad based Dr. Reddy’s Laboratories and Laurus Labs.
G V Prasad, co-chairman and managing director, Dr Reddy’s Laboratories limited, Dr Satyanarayana Chava, CEO, Laurus Labs, Shakthi Nagappan, director, Life Sciences & Pharma and chief executive officer, Hyderabad Pharma City, Government of Telangana and Dr. Srinivas Oruganti, director, Dr Reddy’s Institute of Life Sciences were present during the signing of consortium agreement.
According to K T Rama Rao, this hub would function as a Center of Excellence (CoE) and boost the research activities at the CoE. Further this initiative will also benefit from the scientific mentorship and support from world-renowned scientists like Prof. Goverdhan Mehta (University of Hyderabad) and international advisors such as Prof. Steven Ley (University of Cambridge, UK), Prof. Oliver Kappe (University of Graz, Austria), Prof. Shu Kobayashi (University of Tokyo, Japan).
“With deep expertise in the area of flow chemistry and continuous manufacturing. The Government of Telangana will facilitate strategic support and scale up for the hub by encouraging more industries join the consortium and benefit from it,” informed Jayesh Rajan, principal secretary.
Adding further the industries minister said, “this hub would be an enabler for the pharma industry in India to make a paradigm shift towards incorporation of modern approaches from R&D to manufacturing and migration to greener and sustainable processes. The Government of Telangana is delighted to facilitate and support the establishment of the CoE with the help of Dr Reddy’s Laboratories and Laurus Labs. I congratulate our life sciences team for their efforts for pulling this together”.
CoE is another milestone in accelerating the growth of life sciences sector in the state. This is part of the larger effort of the state become the US$ 100 billion life sciences ecosystem to be developed in India by 2030, said Shakti Nagappan.
Hyderabad is currently regarded as the life sciences capital of India and has become an important life sciences hub in Asia Pacific region. With over 800 pharmaceutical companies, the city hosts the highest number of US FDA approved facilities globally and contributes to about 35 per cent of India’s overall pharmaceutical production.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|